Aktis Oncology, Inc. Common stock — Quarterly Financial Statements (NASDAQ:AKTS) | MetaTrader

Open full chart

Financials

Overview Finanzbericht Statistics Dividends

Quarterly Annual

Market Capitalization N/A
Employee 76
Founded 2020
CEO N/A
Website www.aktisoncology.com
Headquarter Delaware, United States
FIGI BBG00ZQS8KZ1
Industry Technology

Nachrichten

BofA Securities startet Coverage für Akoustis Technologies mit Kaufempfehlung

BofA Securities initiates coverage on Akoustis Technologies stock with Buy rating

TD Cowen startet Coverage für Akoustis Technologies mit Kaufempfehlung

Cowen initiates Akoustis Technologies stock with Buy rating

JPMorgan startet Coverage für Aktis Oncology mit "Overweight"-Rating

Akoustis Technologies stock initiated with Overweight rating by JPMorgan

Wednesday Insider Activity: Mitsui’s $55.6M Berkley Buy Leads the Pack

Insider-Kauf bei Aktis Oncology: Direktor Foley investiert 4,19 Millionen US-Dollar

Aktis Oncology director Foley buys $4.19 million in shares

Aktis Oncology: MPM Funds kauft Aktien im Wert von 20 Mio. US-Dollar

Aktis Oncology: Mpm funds buy shares worth $20m

Aktis Oncology (AKTS) sees $20 million purchase by 10% owner